Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Treatment Outcomes in People with Migraine Receiving Rimegepant or Triptans: A Descriptive Analysis from a Real-World Survey

Author:Abraham, Lucy   Brown, Joshua   Hygge Blakeman, Karin   Feng, Dai   Jackson, James   Whitton, William   Barlow, Sophie   Hancock, Lucy   

Session Name:P1: Headache: Population Health and Outcomes Research  

Topic:Headache  

Program Number:P1.008  

Author Institution:Pfizer R&D UK Ltd, Tadworth, United Kingdom  Pfizer, Inc., New York, NY  Pfizer AB, Stockholm, Sweden  Adelphi Real World, Manchester, United Kingdom  Adelphi Real World, Macclesfield, United Kingdom  

Understanding Healthcare Providers' Perceptions and Prescribing Behaviors of Treatment for Short-Term Prevention of Migraine

Author:Monteith, Teshamae   Chen, Nemin   Cirillo, Jessica   Abraham, Lucy   Jenkins, Aaron   Saccone, Phillip   Leroue, Chelsea   Dai, Feng   Nakajima, Karina   Brighton, Elizabeth   Ailani, Jessica   

Session Name:P5: Headache: Clinically Oriented Research 1  

Topic:Headache  

Program Number:P5.010  

Author Institution:University of Miami, Miami, FL  Oracle Life Sciences, Austin, TX  Pfizer, Inc., Branchburg, NJ  Pfizer, Ltd., Tadworth, United Kingdom  Pfizer, Inc., New York, NY  Pfizer, Inc., New Haven, CT  Pfizer, Inc., Hamden, CT